₹1,396.30
-42.85 (-2.98%)
As of 25 Oct 2026, Venus Remedies Ltd share price is ₹1,396.30. The stock opened at ₹1,396.30 and had closed at ₹1,439.15 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹432.00 and a high of ₹2,043.15. In terms of performance, Venus Remedies Ltd share price has increased by 53.36% over the past six months and has increased by 219.37% over the last year.
VENUSREM Stock Price Chart
Venus Remedies Ltd Overview
Market cap₹1,866 Crs
Volume4,566
Prev. Close₹1,439.15
Year range₹432.00 - ₹2,043.15
ISININE411B01019
About VENUSREM
Venus Remedies a research-driven global pharmaceutical company specializing in critical care, antimicrobial resistance (AMR), and oncology
Venus Remedies Ltd Historical Performance
1 Month Return-15.18%
6 Month Return39.83%
3 Year Return476.15%
3 Month Return-16.69%
1 Year Return210.15%
5 Year Return177.93%
Venus Remedies Ltd Fundamentals
ROCE(TTM)18.61%
P/E Ratio (TTM)16.50
P/B Ratio2.71
Debt to Equity0.02
ROE14.40%
EPS (TTM)84.64
Dividend Yield0.72%
Book Value515.92
Profit Margin13.96%
Operating Margin16.94%
Venus Remedies Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 780.18 | 660.24 | 586.53 | 547.83 | 585.14 |
| EBITDA | 155.37 | 100.68 | 72.20 | 71.70 | 77.25 |
| Net Profit | 99.31 | 52.55 | 30.50 | 28.96 | 48.99 |
| EPS | 74.29 | 39.32 | 22.82 | 21.67 | 37.12 |
Venus Remedies Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,403.60 |
| Resistance 1 (R1) | 1,508.35 |
| Pivot Point | 1,472.80 |
Venus Remedies Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 07-Aug-2026 | 26-May-2026 | 07-Aug-2026 | Final | ₹10.00 |
VENUSREM Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Pawan Chaudhary | Chairman & Managing Director |
| Manu Chaudhary | Whole Time Director |
| Peeyush Jain | Managing Director |
Venus Remedies Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,748.00-0.57% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹8,950.00-2.31% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,524.40-1.97% | ₹1,46,951.32 | 64.68 | 11.42% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Venus Remedies Ltd today is ₹1,396.30 on NSE and ₹1,396.30 on BSE.
- The 52-week high of Venus Remedies Ltd is ₹2,043.15, while the 52-week low is ₹432.00.
- The current market capitalisation of Venus Remedies Ltd is approximately ₹1,866 crore.
- The P/E (Price-to-Earnings) ratio of Venus Remedies Ltd is 11.71. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Venus Remedies Ltd is 1.50. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Venus Remedies Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for VENUSREM on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Venus Remedies Ltd has delivered a return of approximately 476.15%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Venus Remedies Ltd comprises different categories of shareholders. As of Sept 2026, the shareholding is approximately 41.76% promoters, 3.13% FIIs, 0.74% DIIs, and 44.01% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
